Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

Market Cap	11.07B
Revenue (ttm)	6.38B
Net Income (ttm)	595.75M
Shares Out	2.52B
EPS (ttm)	0.23
PE Ratio	19.06
Forward PE	n/a
Dividend	0.20 (4.56%)
Ex-Dividend Date	May 31, 2024

Volume	29,935,692
Average Volume	25,412,768
Open	4.460
Previous Close	4.450
Day's Range	4.380 - 4.470
52-Week Range	3.910 - 5.540
Beta	0.33
RSI	45.84
Earnings Date	Apr 25, 2025

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, manufacturing, and sales of medicines and general health products in China. It offers Chinese herbal decoction pieces, Chinese patent medicines, chemical pharmaceutical products, chemical raw materials, medical devices, and biological products. The company also provides pharmaceutical dosage forms, including tablets, capsules, pills, dripping pills, granules, powders, injections, freeze-dried powder injections, oral liquids, syrups, nasal drops, ointments, etc. The ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 8,411
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600572

Financial Performance

In 2024, SHA:600572's revenue was 6.52 billion, a decrease of -3.23% compared to the previous year's 6.73 billion. Earnings were 622.42 million, an increase of 5.21%.